Access cutting-edge cardiac sarcoidosis treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access cardiac sarcoidosis specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cardiac sarcoidosis treatment provided free
The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after 24 weeks of therapy.
Sponsor: Mayo Clinic
Check if you qualify for this cardiac sarcoidosis clinical trial in Baltimore, MD
If you're searching for cardiac sarcoidosis treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiac sarcoidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.